Get started
Author

Mathieu Beneteau

Observed names: Beneteau, Mathieu, Mathieu BENETEAU
Institution: Ipsen (France)
Observed institution: Ipsen (France)
ORCID: 0009-0001-6741-1328
Observed ORCID: 0009-0001-6741-1328
OpenAlex ID: A5114726742
Longitudinal Goal Attainment With Repeat Injections of AbobotulinumtoxinA in Adults With Lower Limb Spasticity: Results From a Prospective Observational Study
2024 · Alberto Esquenazi, Richard D. Zorowitz, et al. · Archives of Physical Medicine and Rehabilitation · 14
PDF
Prevalence and management of hypertensive patients in clinical practice: Cross-sectional registry in five countries outside the European Union
2016 · Stéphanie Ragot, Mathieu Beneteau, et al. · Blood Pressure · 14
PDF
Muscle selection and dosing in patients undergoing treatment with abobotulinumtoxinA for lower limb spasticity in real-world practice
2025 · Richard D. Zorowitz, Jorge Jacinto, et al. · Journal of Rehabilitation Medicine · 7
PDF
Spasticity Management with Botulinum Toxin in Post-stroke and Multiple Sclerosis Patients: A Retrospective, ‘Real-world’, Multicenter Study
2025 · Calogera Butera, Marcello Esposito, et al. · Neurorehabilitation · 3
PDF
Impact of Early Versus Late Treatment with Botulinum Toxin A on Goal Attainment in Post-Stroke Spasticity: A Retrospective Cohort Study
2026 · Atul Patel, Jinming Zhang, et al. · Toxins · 2
PDF
Evolution of goal setting and attainment over repeated cycles of botulinum toxin A for upper limb spasticity in real-life clinical practice: longitudinal analyses from the observational ULIS-III cohort study
2026 · Lynne Turner-Stokes, Klemens Fheodoroff, et al. · Journal of Rehabilitation Medicine · 1
Abstract TP331: Effectiveness of AbobotulinumtoxinA in Stroke Survivors with Lower Limb Spasticity
2026 · Richard Zorowitz, Stephen Ashford, et al. · Stroke · 1
Longitudinal Goal Attainment Across Four Consecutive Botulinum Toxin Treatment Cycles in Adults with Upper Limb Spasticity (P7-4.001)
2025 · Lynne Turner-Stokes, Jorge Jacinto, et al. · Neurology · 1
Persistence to Botulinum Toxin and Factors Associated With Discontinuation: A Retrospective Cohort Study (P5-14.010)
2026 · Michael Wainberg, Jinming Zhang, et al. · Neurology
Regional Differences in Use of Injection Guidance and Goal Attainment Following Repeat AbobotulinumtoxinA Injections: Subgroup Analysis of the AboLiSh Observational Study (P5-14.004)
2026 · Alberto Esquenazi, Stephen Ashford, et al. · Neurology
A Phase IV, Randomized, Double-Blind, Crossover Study to Compare the Clinical Safety and Efficacy of AbobotulinumtoxinA and OnabotulinumtoxinA in Adult Upper Limb Spasticity
2026 · Alberto Esquenazi, Theodore H. Wein, et al. · Advances in Therapy
PDF
A Phase IV, Randomized, Double-Blind, Crossover Study to Compare the Clinical Safety and Efficacy of AbobotulinumtoxinA and OnabotulinumtoxinA in Adult Upper Limb Spasticity
2026 · Esquenazi, Alberto, H. Wein, Theodore, et al. · Figshare
Abstract Number: Esoc2026a1166 Persistence With Botulinum Toxin a and Factors Associated With Discontinuation in Patients With Stroke: a Retrospective Cohort Study
2026 · Michael Wainberg, Simon Page, et al. · European Stroke Journal
Abstract Number: Esoc2026a357 Sensitivity and Specificity of the Post-stroke Spasticity Monitoring Questionnaire (psmq) for Remote Monitoring of Spasticity Development: Interim Analysis From an Ongoing Epidemiological Study
2026 · Richard Zorowitz, Laura Serrano Barrenechea, et al. · European Stroke Journal
Abstract Number: Esoc2026a374 Effectiveness of Abobotulinumtoxina in Stroke Survivors With Lower Limb Spasticity
2026 · Richard Zorowitz, Stephen Ashford, et al. · European Stroke Journal
Quality of Life Assessment Using the Leg Activity Measure in Ambulatory Individuals With Leg Spasticity: Findings From a Longitudinal, Observational Study Evaluating the Effectiveness of AbobotulinumtoxinA in Routine Practice
2026 · Stephen Ashford, Alberto Esquenazi, et al. · Archives of Rehabilitation Research and Clinical Translation
PDF
Effect of Early Use of Botulinum Toxin A on Goal Attainment in Post-Stroke Spasticity
2026 · Atul Patel, Jinming Zhang, et al. · Toxicon
Quality of Life (QoL) Improvements in Patients With Leg Spasticity Following Treatment With AbobotulinumtoxinA: Assessment Using a Disease-Specific and a Generic QoL Instrument
2026 · Stephen Ashford, Alberto Esquenazi, et al. · Toxicon
Longitudinal Goal Attainment Across Four Consecutive Botulinum Neurotoxin Treatment Cycles in Adults With Upper Limb Spasticity
2026 · Lynne Turner-Stokes, Jorge Jacinto, et al. · Toxicon
Sensitivity and Specificity of the Poststroke Spasticity Monitoring Questionnaire (PSMQ) for Remote Monitoring of Spasticity Development: Interim Analysis From an Ongoing Epidemiology Study
2026 · Richard D. Zorowitz, Laura Serrano Barrenechea, et al. · Toxicon
Identifying Post-Stroke Spasticity in Swedish Healthcare Registers: A Real-World Analysis
2026 · Susanne Palmcrantz, Alexandros Zampakas, et al. · Toxicon
Interim Analysis of the Non-Interventional SMART Study on the Effectiveness and Safety of AbobotulinumtoxinA Injections in Everyday Practice in Patients With Upper Limb Spasticity After Stroke
2026 · Axel Schramm, Emma Zaragatski, et al. · Toxicon
Regional Differences in Use of Injection Guidance and Goal Attainment Following Repeat AbobotulinumtoxinA Injections: Subgroup Analysis of the AboLiSh Observational Study
2026 · Alberto Esquenazi, Stephen Ashford, et al. · Toxicon
Persistence With Botulinum Neurotoxin Type A and Factors Associated With Discontinuation: A Retrospective Cohort Study
2026 · Michael Wainberg, Jinming Zhang, et al. · Toxicon
Achieving treatment goals with repeated injections of botulinum toxin in adults with leg spasticity
2025 · Alberto Esquenazi, Richard D. Zorowitz, et al. · Current Medical Research and Opinion
PDF
Works count: 25
Citation count: 43
H-index: 3
I10-index: 2
Year
Topic
Type